Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients

Author:Novak, Frederik   Bajwa, Hamza   Eugenio Coia, John   Nilsson, Anna Christine   Nielsen, Christian   Holm, Dorte   Østergaard, Kamilla   Hvidt, Mathilde   Byg, Keld-Erik   Johansen, Isik   Mittl, Kristen   Rowles, William   Zamvil, Scott   Bove, Riley   Sabatino, Joseph   Sejbaek, Tobias   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.005  

Author Institution:Southwest Jutland Hospital, Esbjerg, Denmark  University of Southern Denmark, Odense, Denmark  Odense University Hospital, Odense, Denmark  Nordsjællands Hospital, Hillerød, Denmark  Hospitalsenhed Midt, Viborg, Denmark  UCSF, San Francisco, CA  University of CA, San Francisco, San Francisco, CA  University of California, San Francisco, Berkeley, CA  University of California San Francisco, San Francisco, CA  

Amyloid Myopathy as Initial Manifestation of ATTRwt: A Rare Phenomenon

Author:Bovino, Mario   Young Hwang, Jin   Pytel, Peter   Nadkarni, Nitin   Pritikanta, Paul   

Session Name:P9: Neuromuscular Disease: Acquired Myopathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.007  

Author Institution:University of Chicago, Chicago , IL  Weiss Memorial Hospital, Chicago, IL  Center Neurological Disease, Crest Hill, IL  University of Illinois Hospital, Chicago, IL  

Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study

Author:Bowen, James   Stulc, Jessica   Hunter, Samuel   Antezana, Ariel   Chen, Hailu   Lewin, James   Scaramozza, Matthew   Bozin, Ivan   Then Bergh, Florian   

Session Name:P8: MS Therapeutics 2  

Topic:MS and Inflammatory Disease  

Program Number:P8.001  

Author Institution:Swedish Neuroscience Institute, Seattle, WA  Minneapolis Clinic of Neurology, Golden Valley, MN  Advanced Neurosciences Institute, Franklin, TN  Neuromedical Clinic of Central Louisiana, Alexandria, LA  Biogen Inc., Cambridge, MA  University of Leipzig, Klinik u. Poliklinik fuer Neurologie, Leipzig, Germany  

A Longitudinal Experience and Annual “Check-Ins” to Increase Resident EEG and EMG Milestone Attainment and Improve Milestone Rating Accuracy

Author:Sutherland, Harry   Bower, Aaron   Zuchowski, Kathryn   Dewey, Jeffrey   Moeller, Jeremy   

Session Name:P1: Education, Research and Methodology: Resident Education 1  

Topic:Education, Research, and Methodology  

Program Number:P1.002  

Author Institution:Yale School of Medicine, New Haven, CT  Yale School of Medicine, Cheshire, CT  

Clinical Characteristics of Early-Onset Parkinson Disease in Mayo Clinic Population

Author:Ghoniem, Khaled   Jacobson, Jessie   Mullan, Aidan   Turcano, Pierpaolo   Camerucci, Emanuele   Stang, Cole   Bower, James   Savica, Rodolfo   

Session Name:P6: Movement Disorders: Environmental Factors and Phenotyping Parkinsonisms 2  

Topic:Movement Disorders  

Program Number:P6.004  

Author Institution:Mayo Clinic, Rochester, MN  Mayo Clinic , Rochester, MN  Mayo Clinic, Jacksonville, FL  Kansas University Medical Center, Kansas City, KS  Mayo Clinic, Duluth, MN